I D McGilvray
Overview
Explore the profile of I D McGilvray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ivanics T, Rajendran L, Abreu P, Claasen M, Shwaartz C, Patel M, et al.
Ann Med Surg (Lond)
. 2022 May;
77:103645.
PMID: 35637985
Background: Curative-intent therapies for hepatocellular carcinoma (HCC) include radiofrequency ablation (RFA), liver resection (LR), and liver transplantation (LT). Controversy exists in treatment selection for early-stage tumours. We sought to evaluate...
2.
Bodie G, Hagen J, Almamar A, Majumdar S, Wang X, Tuepah R, et al.
Can J Surg
. 2022 Apr;
55(4 Suppl 1):S63-S135.
PMID: 35488395
No abstract available.
3.
Knaak M, Goldaracena N, Doyle A, Cattral M, Greig P, Lilly L, et al.
Am J Transplant
. 2016 Aug;
17(3):754-760.
PMID: 27545327
The increased prevalence of obesity worldwide threatens the pool of living liver donors. Although the negative effects of graft steatosis on liver donation and transplantation are well known, the impact...
4.
Aravinthan A, Doyle A, Issachar A, Dib M, Peretz D, Cattral M, et al.
Am J Transplant
. 2016 Apr;
16(12):3512-3521.
PMID: 27088432
Liver transplantation (LT) is the treatment of choice for end-stage autoimmune liver diseases. However, the underlying disease may recur in the graft in some 20% of cases. The aim of...
5.
Duarte-Rojo A, Fischer S, Adeyi O, Zita D, Deneke M, Selzner N, et al.
J Viral Hepat
. 2015 Dec;
23(5):340-7.
PMID: 26710754
The outcome of triple therapy with protease inhibitors (PI) depends on the intrinsic response to interferon. Interferon-stimulated gene (ISG) expression differs by cell type in the liver and is a...
6.
Goldaracena N, Spetzler V, Marquez M, Selzner N, Cattral M, Greig P, et al.
Am J Transplant
. 2015 Mar;
15(6):1591-7.
PMID: 25799890
We report the outcome of live donor liver transplantation (LDLT) for patients suffering from acute liver failure (ALF). From 2006 to 2013, all patients with ALF who received a LDLT...
7.
Sapisochin G, Goldaracena N, Astete S, Laurence J, Davidson D, Rafael E, et al.
Ann Surg Oncol
. 2014 Dec;
22(7):2286-94.
PMID: 25472651
Purpose: To identify prognostic factors after hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT). Methods: We retrospectively reviewed the combined experience at Toronto General Hospital and Hospital Vall d'Hebron managing...
8.
Goldaracena N, Marquez M, Selzner N, Spetzler V, Cattral M, Greig P, et al.
Am J Transplant
. 2014 Oct;
14(12):2788-95.
PMID: 25277134
Outcomes of living versus deceased donor liver transplantation in patients with chronic liver disease and hepatorenal syndrome (HRS) was compared using a matched pair study design. Thirty patients with HRS...
9.
Kim P, Jang J, Atenafu E, Fischer S, Greig P, McGilvray I, et al.
Br J Surg
. 2013 Sep;
100(11):1516-22.
PMID: 24037575
Background: The role of liver resection in patients with multifocal hepatocellular carcinoma (HCC) with well preserved liver function is controversial. This study was conducted to evaluate the outcomes of such...
10.
Kim P, Wei A, Atenafu E, Cavallucci D, Cleary S, Moulton C, et al.
Br J Surg
. 2013 Aug;
100(10):1349-56.
PMID: 23939847
Background: The management of portal vein (PV) involvement by pancreatic adenocarcinoma during pancreaticoduodenectomy (PD) is controversial. The aim of this study was to compare the outcomes of unplanned and planned...